ClinicalTrials.Veeva

Menu

Concomitant or Sequential Phlebectomy After Endovenous Laser Therapy for Varicose Veins (EVLTAP)

NHS Trust logo

NHS Trust

Status

Completed

Conditions

Phlebectomies
Endovenous Laser Ablation
Varicose Veins

Treatments

Procedure: Endovenous Laser ablation and sequential phlebectomies
Procedure: Endovenous Laser ablation and concomitant phlebectomies

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Varicose veins of the leg often have superficial tributaries, which are often symptomatic and a major reason for coming to the doctor. When treating the main varicose vein inside the leg, some doctors prefer to remove these tributaries while others prefer to leave them. This trial aims to see if it is better to remove these veins at the time of the first laser procedure or better to leave them and only remove them when asked.

Full description

Endovenous laser therapy (EVLT) for varicose veins is associated with high initial occlusion rates, minimal complications and low recurrence rates at 5 years. Randomized trials and meta-analyses have confirmed the efficacy of EVLT in comparison with surgery and other endovenous techniques. There is also evidence that it may be associated with early quality of life (QoL) benefits compared with surgery. The general efficacy of EVLT has therefore been demonstrated and current research focuses on refinement of the procedure. A fundamental question concerns the management of residual varicosities following truncal laser ablation. One approach is to leave these varicosities to regress untouched, minimizing the procedure time and surgical trauma6. This approach, however, is associated with a significant number of secondary and tertiary interventions (sclerotherapy and/or ambulatory phlebectomy). Another option is to combine in a single procedure ambulatory phlebectomy with initial truncal laser ablation (EVLTAP). The aim of this randomized controlled trial was to assess the advantages of performing ambulatory phlebectomy as a concomitant procedure to truncal laser ablation.

Enrollment

50 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • primary, symptomatic, unilateral varicose great saphenous veins (GSV), with isolated saphenofemoral junction (SFJ) incompetence and GSV reflux on venous duplex imaging,
  • perigenicular vein diameter exceeding 4 mm,
  • acceptance by the patient of a local anaesthetic procedure.

Exclusion criteria

  • saphenopopliteal, small saphenous or deep venous incompetence on duplex imaging
  • did not give consent to trial participation.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

50 participants in 2 patient groups

Concomitant phlebectomies
Experimental group
Description:
Removal of varicose tributaries during Endovenous laser ablation
Treatment:
Procedure: Endovenous Laser ablation and sequential phlebectomies
Procedure: Endovenous Laser ablation and concomitant phlebectomies
Sequential Phlebectomies
Active Comparator group
Description:
Endovenous laser ablation only
Treatment:
Procedure: Endovenous Laser ablation and sequential phlebectomies
Procedure: Endovenous Laser ablation and concomitant phlebectomies

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems